8-K
filed June 9, 2026, 5:54 PM ET
ticker PIII
CIK 0001832511
other material
confidence high
sentiment neutral
materiality 0.15
P3 Health Partners shareholders approve all four proposals at 2026 annual meeting
P3 Health Partners Inc.
- Elected three Class II directors: Bacchus (4,067,100 for), Thierer (4,081,573), Leisure (3,980,136).
- Ratified BDO USA as independent auditor for FY2026 (4,484,963 for, 39,585 against).
- Advisory say-on-pay approved (4,084,583 for, 9,786 against).
- Approved issuance of up to 3,341,130 shares upon exercise of warrants held by VBC Growth SPV 5, LLC (4,064,690 for).
Key facts
Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.99
P3 Health Partners Inc. shareholders approved Election of three Class II directors for a term of office expiring on the date of the annual meeting of stockholders to be held in 2029, and until their respective successors have been duly elected and qualified. at the 2026-06-09 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2026-06-09
Exact text from the filing
On June 9, 2026, P3 Health Partners Inc. (the “Company”) held its 2026 Annual Meeting of Stockholders (the “Annual Meeting”).
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.99
P3 Health Partners Inc. shareholders approved Ratification of the appointment of BDO USA, P.C. as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026. at the 2026-06-09 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2026-06-09
Exact text from the filing
On June 9, 2026, P3 Health Partners Inc. (the “Company”) held its 2026 Annual Meeting of Stockholders (the “Annual Meeting”).
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.99
P3 Health Partners Inc. shareholders approved Approval, on an advisory (non-binding) basis, of the compensation of the Company’s named executive officers. at the 2026-06-09 meeting.
- Proposal
- say on pay
- Outcome
- passed
- Meeting
- 2026-06-09
Exact text from the filing
On June 9, 2026, P3 Health Partners Inc. (the “Company”) held its 2026 Annual Meeting of Stockholders (the “Annual Meeting”).
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.99
P3 Health Partners Inc. shareholders approved Approval, in accordance with Nasdaq Listing Rule 5635(d), the issuance of up to 3,341,130 shares of Class A common stock upon the exercise of outstanding Class A common stock warrants held by VBC Growth SPV 5, LLC. at the 2026-06-09 meeting.
- Proposal
- equity plan
- Outcome
- passed
- Meeting
- 2026-06-09
Exact text from the filing
On June 9, 2026, P3 Health Partners Inc. (the “Company”) held its 2026 Annual Meeting of Stockholders (the “Annual Meeting”).
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.